10-Q/A XBRL

10-Q/A

Company: Kalaris Therapeutics, Inc.
Filed: September 16, 2020
Period of Report: June 30, 2020
Accession Number: 0001564590-20-043651

View Document ↗ View on SEC.gov ↗